Details of the Drug

General Information of Drug (ID: DMWQ38D)

• Drug Name: Milatuzumab-doxorubicin conjugate

Indication

Disease Entry	ICD 11	Status	REF
Multiple myeloma	2A83	Phase 1/2	[1]

• Drug Type: Antibody drug conjugate
• Cross-matching ID: TTD ID: D0Y6BO

References

• [1] ClinicalTrials.gov (NCT01101594) A Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma. U.S. National Institutes of Health.